CCL3 and neoplasm: This behaviour is observed clinically, patients with higher MIP-1α levels (increasing β) tend to have more bone resorption and lytic bone lesions (Terpos et al, 2003; Hashimoto et al, 2004) and shorter survival due to a higher tumour burden (Terpos et al, 2003).